Plasma is superior to serum for cfDNA mutation detection and monitoring

Rikke Fredslund Andersen, Karen-Lise Garm Spindler, Anders Jakobsen, Niels Pallisgaard

Research output: Contribution to conference without publisher/journal › Poster › Research

Original language	English
Publication date	2012
Publication status	Published - 2012
Event	The 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics - Dublin, Ireland Duration: 6. Nov 2012 → 9. Nov 2012

Conference	The 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Country/Territory	Ireland
City	Dublin
Period	06/11/2012 → 09/11/2012

Cite this

@conference{4f1a5ed241b74735b32203956392e8bd,

title = "Plasma is superior to serum for cfDNA mutation detection and monitoring",

author = "{Fredslund Andersen}, Rikke and Spindler, {Karen-Lise Garm} and Anders Jakobsen and Niels Pallisgaard",

year = "2012",

language = "English",

note = "The 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics ; Conference date: 06-11-2012 Through 09-11-2012",

}

Plasma is superior to serum for cfDNA mutation detection and monitoring. / Fredslund Andersen, Rikke; Spindler, Karen-Lise Garm; Jakobsen, Anders et al.
2012. Poster session presented at The 24th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Dublin, Ireland.

Research output: Contribution to conference without publisher/journal › Poster › Research